"Vinblastina"@en . . . " "@en . . . . . . . "Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)"@en . . . . "Triphasic: 35 min, 53 min, and 19 hours"@en . . . "For treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma."@en . . "(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine"@en . . "approved"@en . . . . "VLB"@en . . "# Starling D: Two ultrastructurally distinct tubulin paracrystals induced in sea-urchin eggs by vinblastine sulphate. J Cell Sci. 1976 Jan;20(1):79-89. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/942954"@en . " "@en . "98-99%"@en . "Pierre Potier, Pierre Mangeney, Nicole Langlois, Yves Langlois, \"Process for the synthesis of vinblastine and leurosidine.\" U.S. Patent US4305875, issued October, 1977."@en . . . "Vinblastine"@en . . . . . . . . . . . "Vinblastinum"@en . . . . . . . "Oral, mouse: LD₅₀ = 423 mg/kg; Oral, rat: LD₅₀ = 305 mg/kg."@en . "Vincaleukoblastine"@en . . . . . . . . . . . . "Vinblastine"@en . "Humans and other mammals"@en . . . "The major route of excretion may be through the biliary system."@en . . "The antitumor activity of vinblastine is thought to be due primarily to inhibition of mitosis at metaphase through its interaction with tubulin. Vinblastine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death."@en . "Vinblastin"@en . . . . . . . . "865-21-4"@en . .